Mis Pharma Limited
Exception report
for the year ended 31 January 2026
The following differences exist between the previous year's closing balances per the accounts and the current year's opening balances per the Trial Balance:
Tangible fixed assets
Opening balance at 1 February 2025 per TB

Balance at 31 January 2025 per accounts

Difference
£ £ £
Improvements to property (Account 522)
Improvements to property - cost - - -
Improvements to property - depreciation - (47) 47
Improvements to property - net book value
- (47) 47
Computer equipment (Account 526)
Computer equipment - cost 753 799 (46)
Computer equipment - depreciation 47 - 47
Computer equipment - net book value 800 799 1
Reserves
Opening balance at 1 February 2025 per TB

Balance at 31 January 2025 per accounts

Difference
£ £ £
Profit and loss account (Account 968) 19,479 19,478 1
19,479 19,478 1
This page does not form part of the statutory financial statements.
Company registration number: 15448574
Unaudited financial statements
for the year ended 31 January 2026
for
Mis Pharma Limited
Pages for filing with the Registrar
Mis Pharma Limited
Chartered Accountants’ Report to the Director for the preparation of the unaudited financial statements
In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Mis Pharma Limited for the year ended 31 January 2026 which comprise the Profit and loss account, Balance sheet and the notes to the financial statements from the company’s accounting records and from information and explanations you have given us.
This report is made solely to the Director of Mis Pharma Limited, in accordance with the terms of our engagement letter. Our work has been undertaken solely to prepare for your approval the financial statements of Mis Pharma Limited and state those matters that we have agreed to state to them in this report. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Mis Pharma Limited and its Director for our work, or for this report.
It is your duty to ensure that Mis Pharma Limited has kept adequate accounting records and to prepare statutory accounts that give a true and fair view of the assets, liabilities, financial position and profit of Mis Pharma Limited. You consider that Mis Pharma Limited is exempt from the statutory audit requirement for the year.
We have not been instructed to carry out an audit or a review of the accounts of Mis Pharma Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.
Date: 31 October 2026
1
Company registration number: 15448574
Mis Pharma Limited
Balance sheet
as at 31 January 2026
31 Jan 26 31 Jan 25
£ £ £ £
Fixed assets 682 752
Current assets 25,528 26,778
Creditors: amounts falling due within one year (5,628) (8,051)
Net current assets 19,900 18,727
NET ASSETS 20,582 19,479
CAPITAL AND RESERVES 20,582 19,479
Notes
1 Company information
Mis Pharma Limited is a private company registered in England and Wales. Its registered number is 15448574. The company is limited by shares. Its registered office is 109 Walter Street, Blackburn, Lancashire, BB1 1SU.
2 Average number of employees
During the year the average number of employees was 2 (2025 - 2).
The company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies for the year ended 31 January 2026.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges their responsibilities to comply with the Companies Act 2006 in respect to accounting records and the preparation of financial statements.
2
Company registration number: 15448574
Mis Pharma Limited
Balance sheet - continued
as at 31 January 2026
The financial statements have been prepared in accordance with the micro-entity provisions.
The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
Signed by:
Mr M Machhar, Director
30 October 2026
3